Nephros
NEPH
16 hedge funds and large institutions have $45.3M invested in Nephros in 2020 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 4 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
40% more capital invested
Capital invested by funds: $32.4M → $45.3M (+$13M)
4.02% more ownership
Funds ownership: 49.5% → 53.52% (+4%)
16% less funds holding
Funds holding: 19 → 16 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
+$1.8M |
| 2 |
WC
Wexford Capital
West Palm Beach,
Florida
|
+$1.12M |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$84.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.2K |
| 5 |
BA
Bard Associates
Chicago,
Illinois
|
+$34.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Overbrook Management Corp
New York
|
-$659K |
| 2 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
-$502K |
| 3 |
Millennium Management
New York
|
-$154K |
| 4 |
BRWA
B. Riley Wealth Advisors
Boca Raton,
Florida
|
-$99K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10K |
NEPH Hedge Fund Activity: Q4 2020 in Review
16 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q4 2020, worth a combined $45.3M — up 40% from $32.4M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NEPH and 1 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 8 added.
The largest buyer was Cowen Prime Advisors, adding an estimated $1.8M. The largest seller was Overbrook Management Corp, exiting entirely with an estimated $659K sold.
- 16 institutional investors held Nephros (NEPH) as of Q4 2020, down from 19 in Q3 2020.
- Funds reported $45.3M of Nephros stock for Q4 2020, up 40% quarter-over-quarter.
- 1 fund opened new Nephros positions in Q4 2020 and 4 closed out, a net change of -3 holders.
- The largest Nephros buyer in Q4 2020 was Cowen Prime Advisors, an estimated $1.8M added.
- The largest Nephros seller in Q4 2020 was Overbrook Management Corp, an estimated $659K sold.
Based on aggregated 13F filings for Q4 2020.